Addressing low-value pharmacological prescribing in primary prevention of CVD through a structured evidence-based and theory-informed process for the design and testing of de-implementation strategies: the DE-imFAR study.

Alvaro SánchezJose Ignacio PijoanSusana PabloMarta MediavillaRita Sainz de RozasItxasne LekueSusana Gonzalez-LarraganGaspar LantaronJon ArgoteArturo García-ÁlvarezPedro Maria LatorreChristian D HelfrichGonzalo Grandes

Published in: Implementation science : IS (2020)

Clinicaltrials.gov identifier: NCT04022850. Registered 17 July 2019.

Keyphrases

primary care
healthcare
emergency department
adverse drug